Q-omics provides the consensus-scored FRG2EP profile across patient tissues and cancer cell-line models. Additionally, FRG2EP RNA expression shows 649 significant protein co-abundance associations, with the highest sampling consensus in LSCC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for FRG2EP — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with FRG2EP in patient tissues and cancer cell lines. In patient samples, FRG2EP shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set. In cancer cell lines, FRG2EP RNA and mutation anchors are most strongly linked to RNA-expression features, especially in CNS, while CRISPR and shRNA rows add functional-dependency signals in UPPER_AERODIGESTIVE_TRACT.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	649	LSCC (152)	view →
Function (mass-spec)	57	OV (14)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼shRNA
RNA	1,301	CNS (253)	view →
shRNA	1,205	UPPER_AERODIGESTIVE_TRACT (213)	view →